Cognitive frailty, a novel target for the prevention of elderly dependency

Ageing Research Reviews

Volumn 20, Issue , 2015, Pages 1-10

  Ruan, Qingwei ^a,b   Yu, Zhuowei ^a,b   Chen, Ma ^a,b   Bao, Zhijun ^b   Li, Jin ^b   He, Wei ^b  

^a BEIJING HOSPITAL   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Cognitive frailty; Physical frailty; Pre clinical AD; Pre MCI; Pre physical frailty; Subjective cognitive decline

Indexed keywords

AMYLOID BETA PROTEIN; BIOLOGICAL MARKER;

AGING; COGNITIVE DEFECT; COGNITIVE FRAILTY; DISEASE SEVERITY; FRAIL ELDERLY; HUMAN; MILD COGNITIVE IMPAIRMENT; NERVE DEGENERATION; REVIEW; SUBJECTIVE COGNITIVE DECLINE; AGED; ALZHEIMER DISEASE; COGNITION; COGNITION DISORDERS; COMPLICATION; DEPENDENT PERSONALITY DISORDER; METABOLISM; PHYSIOLOGY; PREVENTIVE MEDICINE; PROCEDURES; PSYCHOLOGY;

AGED; AGING; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; COGNITION; COGNITION DISORDERS; DEPENDENCY (PSYCHOLOGY); FRAIL ELDERLY; HUMANS; PREVENTIVE MEDICINE;

EID: 84921414903     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2014.12.004     Document Type: Review

References (112)

1. Abellan van Kan G., Rolland Y., Bergman H., Morley J.E., Kritchevsky S.B., Vellas B. The I.A.N.A Task Force on frailty assessment of older people in clinical practice. J. Nutr. Health Aging 2008, 12(1):29-37.
2. Aisen P.S. Treatment for MCI: is the evidence sufficient?. Neurology 2008, 70(22):2020-2021.
3. Akki A., Yang H., Gupta A., Chacko V.P., Yano T., Leppo M.K., Steenbergen C., Walston J., Weiss R.G. Skeletal muscle ATP kinetics are impaired in frail mice. Age (Dordr.) 2014, 36(1):21-30.
4. Annweiler C., Fantino B., Le Gall D., Schott A.M., Berrut G., Beauchet O. Severe vitamin D deficiency is associated with advanced-stage dementia in geriatric inpatients. J. Am. Geriatr. Soc. 2011, 59:169-171.
5. Arum O., Rickman D.J., Kopchick J.J., Bartke A. The slow-aging growth hormone receptor/binding protein gene-disrupted (GHR-KO) mouse is protected from aging-resultant neuromusculoskeletal frailty. Age (Dordr.) 2014, 36(1):117-127.
6. Auyeung T.W., Lee J.S., Kwok T., Woo J. Physical frailty predicts future cognitive decline - a four-year prospective study in 2737 cognitively normal older adults. J. Nutr. Health Aging 2011, 15(8):690-694.
7. Avila-Funes J.A., Amieva H., Barberger-Gateau P., Le Goff M., Raoux N., Ritchie K., Carrière I., Tavernier B., Tzourio C., Gutiérrez-Robledo L.M., Dartigues J.F. Cognitive impairment improves the predictive validity of the phenotype of frailty for adverse health outcomes: the three-city study. J. Am. Geriatr. Soc. 2009, 57(3):453-461.
8. Barberger-Gateau P., Commenges D., Gagnon M., Letenneur L., Sauvel C., Dartigues J.F. Instrumental activities of daily living as a screening tool for cognitive impairment and dementia in elderly community dwellers. J. Am. Geriatr. Soc. 1992, 40(11):1129-1134.
9. Basaria S., Coviello A.D., Travison T.G., Storer T.W., Farwell W.R., Jette A.M., Eder R., Tennstedt S., Ulloor J., Zhang A., Choong K., Lakshman K.M., Mazer N.A., Miciek R., Krasnoff J., Elmi A., Knapp P.E., Brooks B., Appleman E., Aggarwal S., Bhasin G., Hede-Brierley L., Bhatia A., Collins L., LeBrasseur N., Fiore L.D., Bhasin S. Adverse events associated with testosterone administration. N. Engl. J. Med. 2010, 363:109-122.
10. Bouillon K., Kivimaki M., Hamer M., Sabia S., Fransson E.I., Singh-Manoux A., Gale C.R., Batty G.D. Measures of frailty in population-based studies: an overview. BMC Geriatr. 2013, 21(13):64.
11. Boyle P.A., Buchman A.S., Wilson R.S., Leurgans S.E., Bennett D.A. Physical frailty is associated with incident mild cognitive impairment in community-based older persons. J. Am. Geriatr. Soc. 2010, 58:248-255.
12. Buchman A.S., Boyle P.A., Wilson R.S., Tang Y., Bennett D.A. Frailty is associated with incident Alzheimer's disease and cognitive decline in the elderly. Psychosom. Med. 2007, 69:483-489.
13. Buchman A.S., Schneider J.A., Leurgans S., Bennett D.A. Physical frailty in older persons is associated with Alzheimer disease pathology. Neurology 2008, 71(7):499-504.
14. Buchman A.S., Bennett D.A. Cognitive frailty. J. Nutr. Health Aging 2013, 17(9):738-739.
15. Buchman A.S., Yu L., Wilson R.S., Boyle P.A., Schneider J.A., Bennett D.A. Brain pathology contributes to simultaneous change in physical frailty and cognition in old age. J. Gerontol. A: Biol. Sci. Med. Sci. 2014, pii: glu117.
16. Canevelli M., Adali N., Tainturier C. Cognitive interventions targeting subjective cognitive complaints. Am. J. Alzheimers Dis. Other Demen. 2013, 28(6):560-567.
17. Canevelli M., Troili F., Bruno G. Reasoning about frailty in neurology: neurobiological correlates and clinical perspectives. J. Frailty Aging 2014, 3:18-20.
18. Cano C., Samper-Ternent R., Al Snih S., Markides K., Ottenbacher K.J. Frailty and cognitive impairment as predictors of mortality in older Mexican Americans. J. Nutr. Health Aging 2012, 16:142-147.
19. Caselli R.J., Reiman E.M. Characterizing the preclinical stages of Alzheimer's disease and the prospect of presymptomatic intervention. J. Alzheimers Dis. 2013, 33(Suppl. 1):S405-S416.
20. Cawood A.L., Elia M., Stratton R.J. Systematic review and meta-analysis of the effects of high protein oral nutritional supplements. Ageing Res. Rev. 2012, 11:e278-e296.
21. Chaves P.H., Varadhan R., Lipsitz L.A., Stein P.K., Windham B.G., Tian J., Fleisher L.A., Guralnik J.M., Fried L.P. Physiological complexity underlying heart rate dynamics and frailty status in community-dwelling older women. J. Am. Geriatr. Soc. 2008, 56(9):1698-1703.
22. Clegg A., Barber S., Young J., Forster A., Iliffe S. Do home-based exercise interventions improve outcomes for frail older people? Findings from a systematic review. Rev. Clin. Gerontol. 2012, 22:68-78.
23. Clegg A., Barber S., Young J., Iliffe S., Forster A. The home-based older people's exercise (HOPE) trial: a pilot randomised controlled trial of a home-based exercise intervention for older people with frailty. Age Ageing 2014, 43(5):687-695.
24. Clegg A., Young J., Iliffe S., Rikkert M.O., Rockwood K. Frailty in elderly people. Lancet 2013, 381(9868):752-762.
25. Dartigues J.F., Amieva H. Cognitive frailty: rational and definition from an (I.A.N.A./I.A.G.G.) international consensus group. J. Nutr. Health Aging 2014, 18(1):95.
26. de Vries N.M., Staal J.B., van Ravensberg C.D., Hobbelen J.S., Olde Rikkert M.G., Nijhuis-van der Sanden M.W. Outcome instruments to measure frailty: a systematic review. Ageing Res. Rev. 2011, 10(1):104-114.
27. de Vries N.M., van Ravensberg C.D., Hobbelen J.S., Olde Rikkert M.G., Staal J.B., Nijhuis-van der Sanden M.W. Effects of physical exercise therapy on mobility, physical functioning, physical activity and quality of life in community-dwelling older adults with impaired mobility, physical disability and/or multi-morbidity: a meta-analysis. Ageing Res. Rev. 2012, 11:136-149.
28. Desai A.K., Grossberg G.T., Chibnall J.T. Healthy brain aging: a road map. Clin. Geriatr. Med. 2010, 26(1):1-16.
29. Devlin K.N., Gongvatana A., Clark U.S., Chasman J.D., Westbrook M.L., Tashima K.T., Navia B., Cohen R.A. Neurocognitive effects of HIV, hepatitis C, and substance use history. J. Int. Neuropsychol. Soc. 2012, 18(1):68-78.
30. Doody R.S., Thomas R.G., Farlow M., Iwatsubo T., Vellas B., Joffe S., Kieburtz K., Raman R., Sun X., Aisen P.S., Siemers E., Liu-Seifert H., Mohs R. Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease. N. Engl. J. Med. 2014, 370(4):311-321. Alzheimer's Disease Cooperative Study Steering Committee; Solanezumab Study Group.
31. Dorner T.E., Lackinger C., Haider S., Luger E., Kapan A., Luger M., Schindler K.E. Nutritional intervention and physical training in malnourished frail community-dwelling elderly persons carried out by trained lay buddies: study protocol of a randomized controlled trial. BMC Public Health 2013, 27(13):1232.
32. Eeles E.M., White S.V., O'Mahony S.M., Bayer A.J., Hubbard R.E. The impact of frailty and delirium on mortality in older inpatients. Age Ageing 2012, 41:412-416.
33. Elabd C., Cousin W., Upadhyayula P., Upadhyayula P., Chen R.Y., Chooljian M.S., Li J., Kung S., Jiang K.P., Conboy I.M. Oxytocin is an age-specific circulating hormone that is necessary for muscle maintenance and regeneration. Nat. Commun. 2014, 2014(5):4082.
34. Elwood P.C., Pickering J., Bayer A., Gallacher J.E. Vascular disease and cognitive function in older men in the Caerphilly cohort. Age Ageing 2002, 31(1):43-48.
35. Ensrud K.E., Ewing S.K., Fredman L., Hochberg M.C., Cauley J.A., Hillier T.A., Cummings S.R., Yaffe K., Cawthon P.M. Circulating 25-hydroxyvitamin D levels and frailty status in older women. J. Clin. Endocrinol. Metab. 2010, 95(12):5266-5273. Study of Osteoporotic Fractures Research Group.
36. Ensrud K.E., Blackwell T.L., Cauley J.A., Cummings S.R., Barrett-Connor E., Dam T.T., Hoffman A.R., Shikany J.M., Lane N.E., Stefanick M.L., Orwoll E.S., Cawthon P.M. Circulating 25-hydroxyvitamin D levels and frailty in older men: the osteoporotic fractures in men study. J. Am. Geriatr. Soc. 2011, 59(1):101-106. Osteoporotic Fractures in Men Study Group.
37. Ferrucci L., Cavazzini C., Corsi A., Bartali B., Russo C.R., Lauretani F., Ferrucci L., Cavazzini C., Corsi A.M., Bartali B., Russo C.R., Lauretani F., Bandinelli S., Bandinelli S., Guralnik J.M. Biomarkers of frailty in older persons. J. Endocrinol. Invest. 2002, 25(10 Suppl.):10-15.
38. Ferrucci L., Giallauria F., Schlessinger D. Mapping the road to resilience: novel math for the study of frailty. Mech. Ageing Dev. 2008, 129(11):677-679.
39. Fiatarone M.A., O'Neill E.F., Ryan N.D., Clements K.M., Solares G.R., Nelson M.E., Roberts S.B., Kehayias J.J., Lipsitz L.A., Evans W.J. Exercise training and nutritional supplementation for physical frailty in very elderly people. N. Engl. J. Med. 1994, 330:1769-1775.
40. Fried L.P., Tangen C.M., Walston J., Newman A.B., Hirsch C., Gottdiener J., Seeman T., Tracy R., Kop W.J. Frailty in older adults: evidence for a phenotype. J. Gerontol. A: Biol. Sci. Med. Sci. 2001, 56(3):M146-M156.
41. Fried L.P., Xue Q.L., Cappola A.R., Ferrucci L., Chaves P., Varadhan R., Guralnik J.M., Leng S.X., Semba R.D., Walston J.D., Blaum C.S., Bandeen-Roche K. Nonlinear multisystem physiological dysregulation associated with frailty in older women: implications for etiology and treatment. J. Gerontol. A: Biol. Sci. Med. Sci. 2009, 64(10):1049-1057.
42. Friedlander A.L., Butterfield G.E., Moynihan S., Grillo J., Pollack M., Holloway L., Friedman L., Yesavage J., Matthias D., Lee S., Marcus R., Hoffman A.R. One year of insulin-like growth factor I treatment does not affect bone density, body composition, or psychological measures in ostmenopausal women. J. Clin. Endocrinol. Metab. 2001, 86:1496-1503.
43. Golomb J., Kluger A., Ferris S.H. Mild cognitive impairment: historical development and summary of research. Dialogues Clin. Neurosci. 2004, 6(4):351-367.
44. Gomez-Isla T., Price J.L., McKeel D.W., Morris J.C., Growdon J.H., Hyman B.T. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J. Neurosci. 1996, 16:4491-4500.
45. Gray S.L., LaCroix A.Z., Aragaki A.K., McDermott M., Cochrane B.B., Kooperberg C.L., Murray A.M., Rodriguez B., Black H., Woods N.F. Angiotensin-converting enzyme inhibitor use and incident frailty in women aged 65 and older: prospective findings from the Women's Health Initiative Observational Study. J. Am. Geriatr. Soc. 2009, 57(2):297-303. Women's Health Initiative Observational Study.
46. Gray S.L., Anderson M.L., Hubbard R.A., LaCroix A., Crane P.K., McCormick W., Bowen J.D., McCurry S.M., Larson E.B. Frailty and incident dementia. J. Gerontol. A: Biol. Sci. Med. Sci. 2013, 68(9):1083-1090.
47. Han E.S., Lee Y., Kim J. Association of cognitive impairment with frailty in community-dwelling older adults. Int. Psychogeriatr. 2014, 26(1):155-163.
48. Hayden K.M., Norton M.C., Darcey D., Ostbye T., Zandi P.P., Breitner J.C., Welsh-Bohmer K.A., Cache, County Study Investigators Occupational exposure to pesticides increases the risk of incident AD: the Cache County study. Neurology 2010, 74:1524-1530.
49. Ho Y.Y., Matteini A.M., Beamer B., Fried L., Xue Q.L., Arking D.E., Chakravarti A., Fallin M.D., Walston J. Exploring biologically relevant pathways in frailty. J. Gerontol. A: Biol. Sci. Med. Sci. 2011, 66(9):975-979.
50. Houles M., Canevelli M., Abellan van kan G., Ousset P.J., Cesari M., Vellas B. Frailty and cognition. J. Frailty Aging 2012, 1(2):56-61.
51. Hughes C.P., Berg L., Danziger W.L., Coben L.A., Martin R.L. A new clinical scale for the staging of dementia. Br. J. Psychiatry 1982, 140:566-572.
52. Jessen F., Amariglio R.E., van Boxtel M., Breteler M., Ceccaldi M., Chételat G., Dubois B., Dufouil C., Ellis K.A., van der Flier W.M., Glodzik L., van Harten A.C., de Leon M.J., McHugh P., Mielke M.M., Molinuevo J.L., Mosconi L., Osorio R.S., Perrotin A., Petersen R.C., Rabin L.A., Rami L., Reisberg B., Rentz D.M., Sachdev P.S., de la Sayette V., Saykin A.J., Scheltens P., Shulman M.B., Slavin M.J., Sperling R.A., Stewart R., Uspenskaya O., Vellas B., Visser P.J., Wagner M. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease. Alzheimer's Demen. 2014, Subjective Cognitive Decline Initiative (SCD-I) Working Group, pii: S1552-5260(14)00002-8.
53. Kalyani R.R., Varadhan R., Weiss C.O., Fried L.P., Cappola A.R. Frailty status and altered glucose-insulin dynamics. J. Gerontol. A: Biol. Sci. Med. Sci. 2012, 67(12):1300-1306.
54. Kelaiditi E., Cesari M., Canevelli M., van Kan G.A., Ousset P.J., Gillette-Guyonnet S., Ritz P., Duveau F., Soto M.E., Provencher V., Nourhashemi F., Salvà A., Robert P., Andrieu S., Rolland Y., Touchon J., Fitten J.L., Vellas B. Cognitive frailty: rational and definition from an (I.A.N.A./I.A.G.G.) international consensus group. J. Nutr. Health Aging 2014, 17:726-734. IANA/IAGG.
55. Kulmala J., Nykänen I., Mänty M., Hartikainen S. Association between frailty and dementia: a population-based study. Gerontology 2014, 60(1):16-21.
56. Knopman D.S., Roberts R. Vascular risk factors: imaging and neuropathologic correlates. J. Alzheimers Dis. 2010, 20:699-709.
57. Ko F., Yu Q., Xue Q.L., Yao W., Brayton C., Yang H., Fedarko N., Walston J. Inflammation and mortality in a frail mouse model. Age (Dordr.) 2012, 34(3):705-715.
58. Landi F., Abbatecola A.M., Provinciali M., Corsonello A., Bustacchini S., Manigrasso L., Cherubini A., Bernabei R., Lattanzio F. Moving against frailty: does physical activity matter?. Biogerontology 2010, 11:537-545.
59. Lang P.O., Michel J.P., Zekry D. Frailty syndrome: a transitional state in a dynamic process. Gerontology 2009, 55(5):539-549.
60. Langlois F., Vu T.T., Chasse K., Dupuis G., Kergoat M.J., Bherer L. Benefits of physical exercise training on cognition and quality of life in frail older adults. J. Gerontol. B: Psychol. Sci. Soc. Sci. 2013, 68:400-404.
61. Leng S.X., Yang H., Walston J.D. Decreased cell proliferation and altered cytokine production in frail older adults. Aging Clin. Exp. Res. 2004, 16(3):249-252.
62. Leng S.X., Cappola A.R., Andersen R.E., Blackman M.R., Koenig K., Blair M., Walston J.D. Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty. Aging Clin. Exp. Res. 2004, 16(2):153-157.
63. López-Otín C., Blasco M.A., Partridge L., Serrano M., Kroemer G. The hallmarks of aging. Cell 2013, 153(6):1194-1217.
64. Malafarina V., Uriz-Otano F., Iniesta R., Gil-Guerrero L. Effectiveness of nutritional supplementation on muscle mass in treatment of sarcopenia in old age: a systematic review. J. Am. Med. Dir. Assoc. 2013, 14:10-17.
65. Malmstrom T.K., Morley J.E. Frailty and cognition: linking two common syndromes in older persons. J. Nutr. Health Aging 2013, 17(9):723-725.
66. Matthews F.E., Stephan B.C., McKeith I.G., Bond J., Brayne C., Medical Research Council Cognitive Function and Ageing Study Two-year progression from mild cognitive impairment to dementia: to what extent do different definitions agree?. J. Am. Geriatr. Soc. 2008, 56(8):1424-1433.
67. Millán-Calenti J.C., Tubío J., Pita-Fernández S., Rochette S., Lorenzo T., Maseda A. Cognitive impairment as predictor of functional dependence in an elderly sample. Arch. Gerontol. Geriatr. 2012, 54(1):197-201.
68. Mhaoláin A.M., Gallagher D., Crosby L., Ryan D., Lacey L., Coen R.F., Coakley D., Walsh J.B., Cunningham C., Lawlor B. Frailty and quality of life for people with Alzheimer's dementia and mild cognitive impairment. Am. J. Alzheimers Dis. Other Demen. 2012, 27(1):48-54.
69. Mitchell A.J., Shiri-Feshki M. Rate of progression of mild cognitive impairment to dementia - meta-analysis of 41 robust inception cohort studies. Acta Psychiatr. Scand. 2009, 119(4):252-265.
70. Moeley J.E., Vellas B., van kan G.A., Anker S.D., Bauer J.M., Bernabei R., Cesari M., Chumlea W.C., Doehner W., Evans J., Fried L.P., Guralnik J.M., Katz P.R., Malmstrom T.K., McCarter R.J., Gutierrez Robledo L.M., Rockwood K., von Haehling S., Vandewoude M.F., Walston J. Frailty consensus: a call to action. J. Am. Med. Dir. Assoc. 2013, 14:392-397.
71. Morris J.C. The clinical dementia rating (CDR): current version and scoring rules. Neurology 1993, 43(11):2412-2414.
72. Morris J.C. Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia. Arch. Neurol. 2012, 69(6):700-708.
73. Moskalev A.A., Aliper A.M., Smit-McBride Z., Buzdin A., Zhavoronkov A. Genetics and epigenetics of aging and longevity. Cell Cycle 2014, 13(7):1063-1077.
74. Ng T.P., Feng L., Nyunt M.S. Frailty in older persons: multisystem risk factors and the frailty risk index (FRI). J. Am. Med. Dir. Assoc. 2014, 15(9):635-642.
75. Njegovan V., Hing M.M., Mitchell S.L., Molnar F.J. The hierarchy of functional loss associated with cognitive decline in older persons. J. Gerontol. A: Biol. Sci. Med. Sci. 2001, 56(10):M638-M643.
76. Okonkwo O.C., Cohen R.A., Gunstad J., Tremont G., Alosco M.L., Poppas A. Longitudinal trajectories of cognitive decline among older adults with cardiovascular disease. Cerebrovasc. Dis. 2010, 30(4):362-373.
77. Oosterveld S.M., Kessels R.P., Hamel R., Ramakers I.H., Aalten P., Verhey F.R., Sistermans N., Smits L.L., Pijnenburg Y.A., van der Flier W.M., Olde Rikkert M.G., Melis R.J. The influence of co-morbidity and frailty on the clinical manifestation of patients with Alzheimer's disease. J. Alzheimers Dis. 2014, 42(2):501-509.
78. Panza F., D'Introno A., Colacicco A.M., Capurso C., Parigi A.D., Capurso S.A., Caselli R.J., Pilotto A., Scafato E., Capurso A., Solfrizzi V. Cognitive frailty: predementia syndrome and vascular risk factors. Neurobiol. Aging 2006, 27(7):933-940.
79. Panza F., Solfrizzi V., Frisardi V., Maggi S., Sancarlo D., Adante F., D'Onofrio G., Seripa D., Pilotto A. Different models of frailty in predementia and dementia syndromes. J. Nutr. Health Aging 2011, 15(8):711-719.
80. Pilotto A., Rengo F., Marchionni N., Sancarlo D., Fontana A., Panza F., Ferrucci L. Comparing the prognostic accuracy for all-cause mortality of frailty instruments: a multicentre 1-year follow-up in hospitalized older patients. PLoS ONE 2012, 7(1):e29090. Study Group FIRI-SIGG.
81. Portet F., Ousset P.J., Visser P.J., Frisoni G.B., Nobili F., Scheltens P., Vellas B., Touchon J. Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease. J. Neurol. Neurosurg. Psychiatry 2006, 77(6):714-718. MCI Working Group of the European Consortium on Alzheimer's Disease (EADC).
82. Puts M.T., Lips P., Deeg D.J. Static and dynamic measures of frailty predicted decline in performance-based and self-reported physical functioning. J. Clin. Epidemiol. 2005, 58(11):1188-1198.
83. Puts M.T., Visser M., Twisk J.W., Deeg D.J., Lips P. Endocrine and inflammatory markers as predictors of frailty. Clin. Endocrinol. (Oxf.) 2005, 63(4):403-411.
84. Rejnmark L., Avenell A., Masud T., Anderson F., Meyer H.E., Sanders K.M., Salovaara K., Cooper C., Smith H.E., Jacobs E.T., Torgerson D., Jackson R.D., Manson J.E., Brixen K., Mosekilde L., Robbins J.A., Francis R.M., Abrahamsen B. Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials. J. Clin. Endocrinol. Metab. 2012, 97(8):2670-2681.
85. Robertson D.A., Savva G.M., Kenny R.A. Frailty and cognitive impairment - a review of the evidence and causal mechanisms. Ageing Res. Rev. 2013, 12(4):840-851.
86. Rockwood K. Frailty and its definition: a worthy challenge. J. Am. Geriatr. Soc. 2005, 53(6):1069-1070.
87. Rockwood K., Mitnitski A. Frailty in relation to the accumulation of deficits. J. Gerontol. A: Biol. Sci. Med. Sci. 2007, 62(7):722-727.
88. Sagare A.P., Bell R.D., Zlokovic B.V. Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease. Cold Spring Harb. Perspect. Med. 2012, 2(10). pii: a011452.
89. Sahin E., DePinho R.A. Axis of aging: telomeres, p53 and mitochondria. Nat. Rev. Mol. Cell Biol. 2013, 13:397-404.
90. Shimada H., Makizako H., Doi T., Yoshida D., Tsutsumimoto K., Anan Y., Uemura K., Ito T., Lee S., Park H., Suzuki T. Combined prevalence of frailty and mild cognitive impairment in a population of elderly Japanese people. J. Am. Med. Dir. Assoc. 2013, 14(7):518-524.
91. Sinha M., Jang Y.C., Oh J., Khong D., Wu E.Y., Manohar R., Miller C., Regalado S.G., Loffredo F.S., Pancoast J.R., Hirshman M.F., Lebowitz J., Shadrach J.L., Cerletti M., Kim M.J., Serwold T., Goodyear L.J., Rosner B., Lee R.T., Wagers A.J. Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle. Science 2014, 344(6184):649-652.
92. Song X., Mitnitski A., Rockwood K. Nontraditional risk factors combine to predict Alzheimer disease and dementia. Neurology 2011, 77:227-234.
93. Sperling R.A., Jack C.R., Aisen P.S. Testing the right target and right drug at the right stage. Sci. Transl. Med. 2011, 3(111). 111cm33.
94. Sperling R.A., Karlawish J., Johnson K.A. Preclinical Alzheimer disease - the challenges ahead. Nat. Rev. Neurol. 2013, 9(1):54-58.
95. Sternberg S.A., Wershof Schwartz A., Karunananthan S., Karunananthan S., Bergman H., Mark Clarfield A. The identification of frailty: a systematic literature review. J. Am. Geriatr. Soc. 2011, 59(11):2129-2138.
96. Tavassoli N., Guyonnet S., Abellan Van Kan G., Sourdet S., Krams T., Soto M.E., Subra J., Chicoulaa B., Ghisolfi A., Balardy L., Cestac P., Rolland Y., Andrieu S., Nourhashemi F., Oustric S., Cesari M., Vellas B., Geriatric Frailty Clinic (G.F.C) for Assessment of Frailty and Prevention of Disability Team Description of 1,108 older patients referred by their physician to the Geriatric Frailty Clinic (G.F.C) for Assessment of Frailty and Prevention of Disability at the gerontopole. J. Nutr. Health Aging 2014, 18(5):457-464.
97. Tieland M., Dirks M.L., van der Zwaluw N., Verdijk L.B., van de Rest O., de Groot L.C., van Loon L.J. Protein supplementation increases muscle mass gain during prolonged resistance-type exercise training in frail elderly people: a randomized, double-blind, placebo-controlled trial. J. Am. Med. Dir. Assoc. 2012, 13:713-719.
98. Tieland M., van de Rest O., Dirks M.L., van der Zwaluw N., Mensink M., van Loon L.J., de Groot L.C. Protein supplementation improves physical performance in frail elderly people: a randomized, double-blind, placebo-controlled trial. J. Am. Med. Dir. Assoc. 2012, 13(720):e726.
99. Theou O., Stathokostas L., Roland K.P., Jakobi J.M., Patterson C., Vandervoort A.A., Jones G.R. The effectiveness of exercise interventions for the management of frailty: a systematic review. J. Aging Res. 2011, 2011:569194.
100. Varadhan R., Seplaki C.L., Xue Q.L., Bandeen-Roche K., Fried L.P. Stimulus-response paradigm for characterizing the loss of resilience in homeostatic regulation associated with frailty. Mech. Ageing Dev. 2008, 129(11):666-670.
101. Vellas B., Coley N., Ousset P.J., Berrut G., Dartigues J.F., Dubois B., Grandjean H., Pasquier F., Piette F., Robert P., Touchon J., Garnier P., Mathiex-Fortunet H., Andrieu S. Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial. Lancet Neurol. 2012, 11(10):851-859. GuidAge Study Group.
102. Vellas B., Carrillo M.C., Sampaio C., Brashear H.R., Siemers E., Hampel H., Schneider L.S., Weiner M., Doody R., Khachaturian Z., Cedarbaum J., Grundman M., Broich K., Giacobini E., Dubois B., Sperling R., Wilcock G.K., Fox N., Scheltens P., Touchon J., Hendrix S., Andrieu S., Aisen P., EU/US/CTAD Task Force Members Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force. Alzheimers Dement. 2013, 9(4):438-444.
103. Villeda S.A., Plambeck K.E., Middeldorp J., Castellano J.M., Mosher K.I., Luo J., Smith L.K., Bieri G., Lin K., Berdnik D., Wabl R., Udeochu J., Wheatley E.G., Zou B., Simmons D.A., Xie X.S., Longo F.M., Wyss-Coray T. Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice. Nat. Med. 2014, 20(6):659-663.
104. Walston J., McBurnie M.A., Newman A., Tracy R.P., Kop W.J., Hirsch C.H., Gottdiener J., Fried L.P., Cardiovascular Health Study Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch. Intern. Med. 2002, 162(20):2333-2341.
105. Walston J., Hadley E.C., Ferrucci L., Guralnik J.M., Newman A.B., Studenski S.A., Ershler W.B., Harris T., Fried L.P. Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J. Am. Geriatr. Soc. 2006, 54:991-1001.
106. Walston J., Fedarko N., Yang H., Leng S., Beamer B., Espinoza S., Lipton A., Zheng H., Becker K. The physical and biological characterization of a frail mouse model. J. Gerontol. A: Biol. Sci. Med. Sci. 2008, 63(4):391-398.
107. Wang G.C., Kao W.H., Murakami P., Xue Q.L., Chiou R.B., Detrick B., McDyer J.F., Semba R.D., Casolaro V., Walston J.D., Fried L.P. Cytomegalovirus infection and the risk of mortality and frailty in older women: a prospective observational cohort study. Am. J. Epidemiol. 2010, 171(10):1144-1152.
108. Weiner D.E., Seliger S.L. Cognitive and physical function in chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 2014, 23(3):291-297.
109. Wilkins C.H., Roe C.M., Morris J.C., Galvin J.E. Mild physical impairment predicts future diagnosis of dementia of the Alzheimer's type. J. Am. Geriatr. Soc. 2013, 61(7):1055-1059.
110. Woods A.J., Cohen R.A., Pahor M. Cognitive frailty: frontiers and challenges. J. Nutr. Health Aging 2013, 17(9):741-743.
111. Xue Q.L., Bandeen-Roche K., Varadhan R., Zhou J., Fried L.P. Initial manifestations of frailty criteria and the development of frailty phenotype in the Women's Health and Aging Study II. J. Gerontol. A: Biol. Sci. Med. Sci. 2008, 63(9):984-990.
112. Zlokovic B.V. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat. Rev. Neurosci. 2011, 12(12):723-738.